227 related articles for article (PubMed ID: 1316078)
21. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women.
Henry DC; Bettis RB; Riffer E; Haverstock DC; Kowalsky SF; Manning K; Hamed KA; Church DA
Clin Ther; 2002 Dec; 24(12):2088-104. PubMed ID: 12581547
[TBL] [Abstract][Full Text] [Related]
22. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole.
Gribble MJ; Puterman ML
Am J Med; 1993 Aug; 95(2):141-52. PubMed ID: 8356980
[TBL] [Abstract][Full Text] [Related]
23. Addressing antibiotic resistance.
Gupta K
Am J Med; 2002 Jul; 113 Suppl 1A():29S-34S. PubMed ID: 12113869
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
Gotfried MH; Ellison WT
Am J Med; 1992 Apr; 92(4A):108S-113S. PubMed ID: 1316059
[TBL] [Abstract][Full Text] [Related]
25. Comparative, double-blind, prospective, multicenter trial of temafloxacin versus trimethoprim-sulfamethoxazole in uncomplicated urinary tract infections in women.
Iravani A
Antimicrob Agents Chemother; 1991 Sep; 35(9):1777-81. PubMed ID: 1952847
[TBL] [Abstract][Full Text] [Related]
26. Treatment of complicated urinary tract infections with lomefloxacin compared with that with trimethoprim-sulfamethoxazole.
Nicolle LE; Louie TJ; Dubois J; Martel A; Harding GK; Sinave CP
Antimicrob Agents Chemother; 1994 Jun; 38(6):1368-73. PubMed ID: 8092839
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial agents for treating uncomplicated urinary tract infection in women.
Zalmanovici Trestioreanu A; Green H; Paul M; Yaphe J; Leibovici L
Cochrane Database Syst Rev; 2010 Oct; (10):CD007182. PubMed ID: 20927755
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis.
Colgan R; Johnson JR; Kuskowski M; Gupta K
Antimicrob Agents Chemother; 2008 Mar; 52(3):846-51. PubMed ID: 18086847
[TBL] [Abstract][Full Text] [Related]
29. Ceftibuten and trimethoprim-sulfamethoxazole for treatment of Shigella and enteroinvasive Escherichia coli disease.
Prado D; López E; Liu H; Devoto S; Woloj M; Contrini M; Murray BE; Gómez H; Cleary TG
Pediatr Infect Dis J; 1992 Aug; 11(8):644-7. PubMed ID: 1523076
[TBL] [Abstract][Full Text] [Related]
30. The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study.
Singh R; Bemelman FJ; Hodiamont CJ; Idu MM; Ten Berge IJ; Geerlings SE
BMC Infect Dis; 2016 Feb; 16():90. PubMed ID: 26912326
[TBL] [Abstract][Full Text] [Related]
31. Comparison of enoxacin versus trimethoprim-sulfamethoxazole in the treatment of patients with complicated urinary tract infection.
Gottlieb PL
Clin Ther; 1995; 17(3):493-502. PubMed ID: 7585853
[TBL] [Abstract][Full Text] [Related]
32. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy.
Perfetto EM; Keating K; Merchant S; Nichols BR
J Manag Care Pharm; 2004; 10(1):17-25. PubMed ID: 14720102
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections.
Cox CE
Am J Med; 1992 Apr; 92(4A):82S-86S. PubMed ID: 1316077
[TBL] [Abstract][Full Text] [Related]
34. A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
Kemper P; Köhler D
Am J Med; 1992 Apr; 92(4A):98S-102S. PubMed ID: 1316079
[TBL] [Abstract][Full Text] [Related]
35. Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection.
Hooton TM
Int J Antimicrob Agents; 2003 Oct; 22 Suppl 2():65-72. PubMed ID: 14527774
[TBL] [Abstract][Full Text] [Related]
36. Norfloxacin compared to trimethoprim/sulfamethoxazole for the treatment of travelers' diarrhea among U.S. military personnel deployed to South America and West Africa.
Thornton SA; Wignall SF; Kilpatrick ME; Bourgeois AL; Gardiner C; Batchelor RA; Burr DH; Oprandy JJ; Garst P; Hyams KC
Mil Med; 1992 Feb; 157(2):55-8. PubMed ID: 1603387
[TBL] [Abstract][Full Text] [Related]
37. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study.
Grassi C; Albera C; Pozzi E
Am J Med; 1992 Apr; 92(4A):103S-107S. PubMed ID: 1316058
[TBL] [Abstract][Full Text] [Related]
38. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
[TBL] [Abstract][Full Text] [Related]
39. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
[TBL] [Abstract][Full Text] [Related]
40. Addressing antibiotic resistance.
Gupta K
Dis Mon; 2003 Feb; 49(2):99-110. PubMed ID: 12601340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
